An Israeli biotechnology company is developing immunotherapy that's designed to prevent cancer from returning.

A biotechnical company in Israel has produced a ground-breaking therapeutic vaccine for cancer patients which could prevent about 90 percent of cancers from coming back, including prostate and breast cancer, solid and non-solid tumours.